FENNEC PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $29.1M | $30.3M |
| FY2021 | — | $15.8M | $21.1M |
| FY2022 | $24.9M | $-2.6M | $23.8M |
| FY2023 | $30.9M | $9.6M | $13.3M |
| FY2024 | $19.3M | $-5.9M | $26.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $29.1M | $30.3M |
| FY2021 | — | $15.8M | $21.1M |
| FY2022 | $24.9M | $-2.6M | $23.8M |
| FY2023 | $30.9M | $9.6M | $13.3M |
| FY2024 | $19.3M | $-5.9M | $26.6M |